ARG1 is a cytoplasmic protein, while ARG2 is mainly localized in the mitochondria (Pilanc et al., 2021), closely associated with poor prognosis through degradation of L-arginine and thus inhibiting the anti-tumor effects of various types of cells in TME antitumor effects and promotes tumor cell proliferation. The gene discussed is ARG1; the disease is neoplasm.